Results 71 to 80 of about 7,937 (220)
Utilization and Prognosis of Cardiac Device Implantation in AL Versus ATTR Amyloidosis
ABSTRACT Introduction Cardiac amyloidosis can cause congestive heart failure, arrhythmias, and heart blocks, which frequently require cardiac device implantation (CDI). However, the differences between light chain (AL) amyloidosis and transthyretin (ATTR) amyloidosis CDI requirements are unknown. Methods A retrospective analysis was conducted using the
Bilal Hussain +7 more
wiley +1 more source
Early-stage amyloid transthyretin cardiomyopathy: uncertainties and opportunities
This editorial refers to ‘Characteristics and natural history of early-stage cardiac transthyretin amyloidosis’, by S. Law et al., https://doi.org/10.1093/eurheartj/ehac259. Amyloid transthyretin cardiomyopathy (ATTR-CM) used to be considered a rare disorder whose diagnosis required a tissue biopsy and which had no treatment options.
Rapezzi C., Serenelli M., Aimo A.
openaire +3 more sources
ABSTRACT Amyloidosis is a rare disease associated with the deposition of misfolded proteins that damage multiple organs, leading to a wide range of symptoms. The most frequently implicated proteins in amyloidosis include immunoglobulin Free Light Chains (FLC), related to AL amyloidosis, and transthyretin (TTR), which is responsible for ATTR amyloidosis.
Paulina Kryszpin +8 more
wiley +1 more source
Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. [PDF]
Cardiovascular Magnetic Resonance is increasingly used to differentiate the aetiology of cardiomyopathies. Late Gadolinium Enhancement (LGE) is the reference standard for non-invasive imaging of myocardial scar and focal fibrosis and is valuable in the ...
A Gulati +58 more
core +3 more sources
ABSTRACT Background Hereditary transthyretin‐mediated amyloidosis (hATTR) is a disorder that affects several body systems and can result in life‐threatening conditions like cardiomyopathy and polyneuropathy. For treatment of hATTR in the new medical realm, there is a breakthrough discovery of a medicine called Eplontersen, which targets the underlying ...
Zeel Vishnubhai Patel +8 more
wiley +1 more source
Summary: Amyloidogenic transthyretin (ATTR) amyloidosis is a relentlessly progressive disease caused by the misfolding and systemic accumulation of amyloidogenic transthyretin into amyloid fibrils.
Rose Pedretti, BS +7 more
doaj +1 more source
Hereditary transthyretin amyloid cardiomyopathy is cardiac involvement in systemic transthyretin amyloidosis. For the first time, we generated induced pluripotent stem cell (iPSC) line of hATTR-CM carrying the TTR mutation p.Asp38Asn.
Shan He +9 more
doaj +1 more source
Rapid progression of aortic and mitral stenosis in a patient with AA amyloidosis: a case report [PDF]
Background: Aortic stenosis is a common finding in cardiac amyloidosis (CA). Younger patients often remain asymptomatic. If unrecognized, this can lead to serious complications such as heart failure.
Frumkin, David +3 more
core +1 more source
Cerebrovascular Involvement in Transthyretin Amyloid Cardiomyopathy
Background: Intracardiac thrombosis is common in transthyretin amyloid cardiomyopathy (ATTR-CM), and patients are at risk for thromboembolic events. However, silent cerebral infarcts and the extent of cerebral small vessel disease in patients with cardiac amyloidosis are unknown.
Lukas Haider +8 more
openaire +2 more sources
Conservative Management of Bilateral Spontaneous Pneumothorax
Bilateral simultaneous spontaneous pneumothorax is a rare occurrence that generally requires prompt intervention. We report a case of simultaneous bilateral spontaneous pneumothorax that was conservatively managed. ABSTRACT Bilateral simultaneous spontaneous pneumothorax is a rare occurrence that generally requires prompt intervention. We report a case
Hanson Siu, Chuan T. Foo
wiley +1 more source

